Sayeh Jalali

Sayeh Jalali

Auto-generated profile, based on publicly available information

Sayeh Jalali

School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2025 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
AAAlireza Azarboo
Alireza Azarboo
PFParisa Fallahtafti
Parisa Fallahtafti
SJSayeh Jalali
Sayeh Jalali
ASAmirhossein Shirinezhad
Amirhossein Shirinezhad
RARamin Assempoor
Ramin Assempoor
AGAmirhossein Ghaseminejad-Raeini
Amirhossein Ghaseminejad-Raeini
Metabolic syndrome (MetS) is a multifactorial condition linked to increased risk of cardiovascular disease and type 2 diabetes. The Single-Point Insulin Sensitivity Estimator (SPISE), a non-invasive index calculated via 600 × HDL-C^0.185 / (TG^0.2 × BMI^1.338), offers a practical alternative. This systematic review and meta-analysis aim to evaluate the accuracy of SPISE as an indicator for MetS. We conducted a systematic review and meta-analysis following PRISMA guidelines. We searched databases such as MEDLINE, Scopus, Web of Science, and Embase, focusing on studies evaluating SPISE's screening accuracy for MetS. Eligible studies were observational, reporting mean SPISE values and its predictive performance. Meta-analyses were performed using Hedges' g standardized mean differences (SMD) and pooled area under the curve (AUC) estimates. Seven studies comprising 12,919 participants were included, with an age range of 9.2 ± 2.1 to 52.4 ± 11.0. Individuals with MetS had significantly lower SPISE scores than controls (SMD = -0.94, 95% CI: -1.25 to -0.63). The pooled AUC for SPISE as a predictor of MetS was 0.86 (95% CI: 0.83 to 0.90), surpassing other insulin resistance indices like HOMA-IR and the triglyceride/HDL-C ratio. Meta-regression showed that systolic and diastolic blood pressure were potential sources of heterogeneity and age, gender, BMI, waist circumference, fasting blood glucose, triglyceride, and HDL did not contribute to heterogeneity. SPISE is a highly accurate and non-invasive tool for predicting MetS, potentially outperforming traditional indices like HOMA-IR. Its ease of use and precision make it a valuable clinical screening tool, especially in diverse populations.

25 July 2025 in Journal of Ovarian Research
Verified
Journal Article
Open access
PDF file
AJAmin Javidan
Amin Javidan
AAAlireza Azarboo
Alireza Azarboo
SJSayeh Jalali
Sayeh Jalali
PFParisa Fallahtafti
Parisa Fallahtafti
SMShabboo Moayyed
Shabboo Moayyed
SHSedigheh Hantoushzade
Sedigheh Hantoushzade
Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age. The triglyceride-glucose (TyG) index, a surrogate marker of insulin resistence, has gained attention for its simplicity and diagnostic accuracy across metabolic disorders. This study aims to assess the association of the TyG index with PCOS. A systematic review and meta-analysis were conducted following PRISMA guidelines. PubMed, Scopus, Embase, and Web of Science were searched up to December 2024. Observational studies reporting TyG indices in PCOS and control groups were included. Subgroup and meta-regression analyses explored sources of heterogeneity. Sensitivity analysis and publication bias assessments ensured robustness. Fifteen studies (7,175 participants) were analyzed. The TyG index was significantly higher in women with PCOS compared to non-PCOS controls (SMD 0.34, 95% CI 0.14–0.54). Subgroup analysis revealed a significant association in Chinese studies (SMD 0.42, 95% CI 0.35–0.49) and cross-sectional studies (SMD 0.45, 95% CI 0.32–0.57). The TyG index exhibited excellent diagnostic accuracy for distinguishing PCOS patients with metabolic syndrome (AUC 0.91, 95% CI 0.85–0.96). Similarly, the TyG-BMI index showed a significant association with PCOS (SMD 0.34, 95% CI 0.10–0.57) and considerable diagnostic performance for insulin resistance in PCOS population (AUC 0.81, 95% CI 0.75–0.88). Meta-regression analysis identified no significant impact of age, body mass index (BMI), or lipid profiles on heterogeneity. The TyG index demonstrates strong potential for PCOS screening, though cut-off values require further validation and accuracy may differ across populations.

19 November 2024 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
SJSayeh Jalali
Sayeh Jalali
NZNegar Zareshahi
Negar Zareshahi
ABAmir Hossein Behnoush
Amir Hossein Behnoush
AAAlireza Azarboo
Alireza Azarboo
ASAmirhossein Shirinezhad
Amirhossein Shirinezhad
AGAmirhossein Ghaseminejad-Raeini
Amirhossein Ghaseminejad-Raeini
Erectile dysfunction (ED) has been linked to insulin resistance (IR), with various surrogate indices being used to assess this association. This systematic review and meta-analysis aimed to evaluate the relationship between IR indices and the incidence and severity of ED. A comprehensive search across PubMed, Embase, Web of Science, and Scopus was carried out. Required data were extracted and meta-analyzed. The Newcastle–Ottawa Scale (NOS) was employed to evaluate the studies' risk of bias. Sensitivity analyses and meta-regressions were conducted to explore heterogeneity and the impact of confounding variables. Seventeen studies with a total of 3810 patients with ED and 8252 without ED were included. Meta-analysis revealed that males with ED had significantly higher levels of Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) (SMD = 0.59, 95% CI [0.15, 1.03], I2 = 82%, P < 0.01), Triglyceride-Glucose Index (TyG) (SMD = 0.53, 95% CI [0.31, 0.75], I2 = 69%, P < 0.01), and Visceral Adiposity Index (VAI) (SMD = 0.45, 95% CI [0.25, 0.64], I2 = 76%, P < 0.01) compared to those without ED. However, there was no significant correlation between a one-unit increase in HOMA-IR (OR = 0.63, 95% CI [0.03, 13.69], I2 = 91%, P = 0.77) or TyG (OR = 0.53, 95% CI [0.02, 11.53], I2 = 88%, P = 0.68) and the odds of ED. Additionally, a one-unit increase in VAI was associated with more severe ED (SMD = 0.34, 95% CI [0.03, 0.64], I2 = 16%, P = 0.03). The diagnostic accuracy of these indices varied. The results indicate a significant connection between insulin resistance and erectile dysfunction, as shown by HOMA-IR, TyG, and VAI. Yet, their usefulness in predicting ED is restricted because of significant differences and inconsistencies in diagnostic precision. More research is required to determine the clinical importance of these indices in treating ED.

13 September 2024 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
AGAmirhossein Ghaseminejad-Raeini
Amirhossein Ghaseminejad-Raeini
AAAlireza Azarboo
Alireza Azarboo
NZNegar Zareshahi
Negar Zareshahi
SJSayeh Jalali
Sayeh Jalali
PFParisa Fallahtafti
Parisa Fallahtafti
AHAmir Human Hoveidaei
Amir Human Hoveidaei

22 May 2025 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
AJAmin Javidan
Amin Javidan
AAAlireza Azarboo
Alireza Azarboo
SJSayeh Jalali
Sayeh Jalali
PFParisa Fallahtafti
Parisa Fallahtafti
YSYeganeh Azimi Shahrabi
Yeganeh Azimi Shahrabi
AFAmir Fathi
Amir Fathi

7 December 2025 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
AAAlireza Azarboo
Alireza Azarboo
SJSayeh Jalali
Sayeh Jalali
FSFarhad Shaker
Farhad Shaker
AKAmirmohammad Khalaji
Amirmohammad Khalaji
RARamin Assempoor
Ramin Assempoor
Cannavo AlessandroCannavo Alessandro
Cannavo Alessandro
Metformin is a cornerstone treatment for diabetes that has demonstrated significant cardioprotective effects. Studies in animals and humans supported metfo